COX-2/15-LOX-IN-6
COX-2/15-LOX-IN-6 (Compound 5l) is the dual inhibitor for COX-2 and 15-LOX, with IC50 of 0.201 μM and 11.723 μM. COX-2/15-LOX-IN-6 inhibits the expression of PGE, TNF-α, IL-6 and iNOS in serum, and exhibits anti-inflammatory effect in Carrageenan -induced rats edema model[1].
Product Specifications
UNSPSC
12352005
Target
COX; Lipoxygenase
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cox-2-15-lox-in-6.html
Smiles
COC1=CC=C(C2=NN(C3=NC(C4=CC=C(OC)C=C4)=CS3)C(C5=CC6=C(C=CC(OC)=C6)N=C5OC)C2)C=C1
Molecular Formula
C31H28N4O4S
Molecular Weight
552.64
References & Citations
[1]Hegazy ME, et al., Tailored quinoline hybrids as promising COX-2/15-LOX dual inhibitors endowed with diverse safety profile: Design, synthesis, SAR, and histopathological study. Bioorg Chem. 2024 Apr;145:107244.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
15-LOX; COX-2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog